Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Debt / NOTE 4/0
-
Number of holders
-
39
-
Total principal
-
485M
-
Principal change
-
-21.3M
-
Total reported value, excl. options
-
$484M
-
Value change
-
-$20.9M
-
Number of buys
-
18
-
Number of sells
-
-15
-
Price
-
$0.99
Significant Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q3 2022
39 filings reported holding 462222AD2 - IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q3 2022.
IONIS PHARMACEUTICALS INC - NOTE 4/0 has 39 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $485M of principal
.
Largest 10 bondholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ($128M of principal), WOLVERINE ASSET MANAGEMENT LLC ($107M of principal), BlackRock Inc. ($27.1M of principal), MACKAY SHIELDS LLC ($24.5M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($20M of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($18.7M of principal), CALAMOS ADVISORS LLC ($17.3M of principal), Magnetar Financial LLC ($16.7M of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($15.5M of principal), and STATE STREET CORP ($15.4M of principal).
This table shows the top 39 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.